Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
收藏Global Health Data Exchange ()2024-06-26 收录
下载链接：
https://ghdx.healthdata.org/record/rosiglitazone-evaluated-cardiovascular-outcomes-oral-agent-combination-therapy-type-2
下载链接
链接失效反馈官方服务：
资源简介：
Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
